Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01468480
Other study ID # p/261/d
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received November 4, 2011
Last updated November 8, 2011
Start date June 2010
Est. completion date March 2011

Study information

Verified date November 2011
Source Islamic Azad University, Tehran
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

Application of four different pulp capping methods on human sound premolars after intentional exposure of the buccal pulp horn through a class one occlusal cavity.


Description:

The purpose of this clinical trial is to compare the effect of different direct pulp capping methods on human pulpal response in the terms of inflammation & dentinal bridge formation. Methods: Eight patients providing 32 sound first premolars are selected. As recommended by ISO / TC 7405 pulpal exposure will be performed through a class I cavity. Four groups of eight specimens each will be defined according to the pulp capping method. Group A, will receive chemical set calcium hydroxide (Dycal). Group B, will receive mineral Trioxide Aggregate (MTA) according to manufacturer's instruction. Group C, will receive MTA and after its primary setting, within 15 minutes, the cavity is restored in the same appointment. Group D, will receive Multical as a direct pulp capping agent. Specimens will be assessed in the terms of dentinal bridge formation, its appearance compared to natural dentin, its thickness and inflammatory pulpal response. The last item will be scored 0-3 in which 0 corresponds to none, 1 to minimal, 2 to moderate and 3 to severe inflammation. In case of an abscess or true tissue necrosis, a score of 4 will be given as recommended by ISO / TC 7405.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date March 2011
Est. primary completion date February 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 10 Years to 16 Years
Eligibility Inclusion Criteria:

- Patients aging from 10 to 16

- Patients who need to extract 4 premolars for orthodontic purposes

- the teeth should be free of caries and clinical symptoms

- Through thermal tests and radiographic examination absence of any pathology is confirmed.

- Periapical radiographs demonstrating absence of any pathology

- no sensitivity to percussion, palpation and biting, no sensitivity to cold after 5 seconds contact with Green Endo Ice refrigerant spray, heat sensitivity after applying tempered Gutta Percha for 10 seconds.

- Absence of any systematic disorder

- No consumption of drugs of any kind

- All patients and their parents need to sign a fully informed consent.

Exclusion Criteria:

- If any of the teeth shows caries, restoration, crack or hypocalcification

- presence of any periapical pathosis

- Teeth that seem sensitive to cold, hot, percussion or pressure

- any systematic disorder

- consumption of drugs of any kind.

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Pro Root MTA
application of MTA in second group and 24 hour interval before restoration
Pro Root MTA- single visit
application of MTA in third group and 15 minute interval before restoration
MultiCal
application of Multical in forth group as a pulp dressing agent
Dycal
application of Dycal in first group as a pulp dressing agent

Locations

Country Name City State
Iran, Islamic Republic of Mahta Fazlyab Tehran

Sponsors (1)

Lead Sponsor Collaborator
Islamic Azad University, Tehran

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary histologic findings - inflammation of the pulp According to histological evaluation and ISO/DIS7405, the investigators gave to non inflamed cases no points, mild cases 1 point, moderate cases 2 points, severe cases 3 points and necrosis 4 points. 6weeks Yes
Secondary histologic findings - formation of the dentinal bridge The specimens will be evaluated in the terms of dentinal bridge formation and its resemblence to natural dentin and also the thickness of the bridge. 6 weeks Yes
See also
  Status Clinical Trial Phase
Completed NCT02019563 - MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial Phase 2
Completed NCT00812877 - Pulp Capping With Two Different Agents N/A
Not yet recruiting NCT04330768 - Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial N/A
Completed NCT02789423 - Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth N/A
Completed NCT02487329 - The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping N/A
Completed NCT00187850 - The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy N/A
Completed NCT03631511 - Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA N/A
Completed NCT02492841 - Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth Phase 2/Phase 3